HUMAW - Humacyte Inc. (HUMA) Q4 2023 Earnings Call Transcript
2024-03-22 12:05:25 ET
Humacyte, Inc. (HUMA)
Q4 2023 Earnings Conference Call
March 22, 2024 08:00 AM ET
Company Participants
Lauren Marek - Investor Relations, LifeSci Advisors
Laura Niklason - President and Chief Executive Officer
Dale Sander - Chief Financial Officer and Chief Corporate Development Officer
Conference Call Participants
Ryan Zimmerman - BTIG
Kristen Kluska - Cantor Fitzgerald & Co.
Joshua Jennings - TD Cowen
Allison Bratzel - Piper Sandler
Vernon Bernardino - H.C. Wainwright
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Humacyte 2023 Fourth Quarter Year-End Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded.
I will now turn the call over to Lauren Marek with LifeSci Advisors. Please go ahead.
Lauren Marek
Thank you, operator. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC.
The forward-looking statements made during this call speak only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, except as required by law. Information presented on this call is contained in the press release we issued this morning and in our Form 10-K, which after filing may be accessed from the Investors page of the Humacyte website....
Humacyte, Inc. (HUMA) Q4 2023 Earnings Call Transcript